Published in Int Rev Psychiatry on December 01, 2013
Regional brain shrinkage and change in cognitive performance over two years: The bidirectional influences of the brain and cognitive reserve factors. Neuroimage (2015) 0.85
Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutr J (2014) 0.81
Clinical workout for the early detection of cognitive decline and dementia. Eur J Clin Nutr (2014) 0.78
Morphologic and neuropsychological patterns in patients suffering from Alzheimer's disease. Neuroradiology (2016) 0.76
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc (2002) 9.81
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Age, neuropathology, and dementia. N Engl J Med (2009) 6.36
Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology (1993) 5.72
Pathogenesis of leukoaraiosis: a review. Stroke (1997) 4.95
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke (2010) 3.75
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (2005) 3.34
Subcortical ischaemic vascular dementia. Lancet Neurol (2002) 3.32
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology (2006) 3.22
Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 3.17
Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 2.97
Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke (1998) 2.83
White matter lesions impair frontal lobe function regardless of their location. Neurology (2004) 2.77
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology (2004) 2.63
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke (2008) 2.48
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol (2002) 2.27
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology (2002) 2.09
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology (2004) 2.00
Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry (2009) 1.97
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol (2008) 1.93
Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology (2005) 1.70
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry (2004) 1.54
White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol Aging (2009) 1.52
Cognitive impairment risk: white matter hyperintensity progression matters. Neurology (2009) 1.46
Regional white matter and neuropsychological functioning across the adult lifespan. Biol Psychiatry (2006) 1.44
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology (2011) 1.43
MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study. Neurobiol Aging (2006) 1.41
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition. Brain (2011) 1.41
Relation of education to brain size in normal aging: implications for the reserve hypothesis. Neurology (1999) 1.38
Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol (2010) 1.36
Influence of education on the relationship between white matter lesions and cognition. Neurology (2003) 1.35
Exploring the neural basis of cognitive reserve in aging. Biochim Biophys Acta (2011) 1.34
Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.34
White matter lesions and cognitive performance: the role of cognitively complex leisure activity. J Gerontol A Biol Sci Med Sci (2008) 1.33
Vascular burden and Alzheimer disease pathologic progression. Neurology (2012) 1.31
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology (2009) 1.30
Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology (2012) 1.22
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord (2004) 1.22
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol (2008) 1.18
White matter hyperintensities predict amyloid increase in Alzheimer's disease. Neurobiol Aging (2012) 1.12
White matter lesions and brain atrophy: more than shared risk factors? A systematic review. Cerebrovasc Dis (2009) 1.11
Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project. J Neurol Sci (2007) 1.07
Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry (1991) 1.07
The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases. Brain (2011) 1.07
The relation of white matter hyperintensities to cognitive performance in the normal old: education matters. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2006) 1.07
Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J Alzheimers Dis (2012) 1.07
Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg Psychiatry (2004) 1.06
White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke (2012) 1.05
Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology (2004) 1.04
Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 1.04
White matter microstructure in relation to education in aging and Alzheimer's disease. J Alzheimers Dis (2009) 1.03
Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke (2009) 1.03
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry (1998) 1.02
Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging (2008) 1.01
Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults. J Neuroimaging (2007) 0.97
White matter lesions on brain magnetic resonance imaging scan and 5-year cognitive decline: the Honolulu-Asia aging study. J Am Geriatr Soc (2011) 0.95
Joint effect of white matter lesions and hippocampal volumes on severity of cognitive decline: the 3C-Dijon MRI study. J Alzheimers Dis (2010) 0.93
Education, atrophy, and cognitive change in an epidemiological sample in early old age. Am J Geriatr Psychiatry (2009) 0.92
Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patients. Stroke (2008) 0.90
Possible retrogenesis observed with fiber tracking: an anteroposterior pattern of white matter disintegrity in normal aging and Alzheimer's disease. J Alzheimers Dis (2011) 0.89
Neuroimaging predictors of death and dementia in a cohort of older stroke survivors. J Neurol Neurosurg Psychiatry (2011) 0.88
Hypertensive target-organ damage in the very elderly. Hypertension (2003) 0.87
Head size may modify the impact of white matter lesions on dementia. Neurobiol Aging (2011) 0.86
Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia. Am J Geriatr Psychiatry (2013) 0.86
Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia. PLoS One (2013) 0.84
Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2013) 0.84
White Matter Lesion Assessment in Patients with Cognitive Impairment and Healthy Controls: Reliability Comparisons between Visual Rating, a Manual, and an Automatic Volumetrical MRI Method-The Gothenburg MCI Study. J Aging Res (2013) 0.82
Does vascular burden contribute to the progression of mild cognitive impairment to dementia? Dement Geriatr Cogn Disord (2012) 0.81
Cerebrovascular assessment for the risk prediction of Alzheimer's disease. J Alzheimers Dis (2012) 0.79
Do cerebral white matter lesions influence the rate of progression from mild cognitive impairment to dementia? Int Psychogeriatr (2012) 0.79
Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention. Transl Psychiatry (2012) 0.77
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Mild cognitive impairment. Lancet (2006) 10.21
Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City study. Arch Intern Med (2009) 3.38
Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ (2006) 2.79
Sleep and depression. J Clin Psychiatry (2005) 2.78
Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn (2004) 2.71
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
Anxiety and mortality risk in community-dwelling elderly people. Br J Psychiatry (2013) 2.13
Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc (2009) 1.87
Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens (2008) 1.79
Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci (2008) 1.70
Resilience and mental health. Clin Psychol Rev (2010) 1.64
Alternative Healthy Eating Index and mortality over 18 y of follow-up: results from the Whitehall II cohort. Am J Clin Nutr (2011) 1.54
Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort. BMC Geriatr (2009) 1.50
Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord (2006) 1.42
Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke (2009) 1.38
Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens (2006) 1.34
Insomnia symptoms in older adults: associated factors and gender differences. Am J Geriatr Psychiatry (2011) 1.28
Ascertaining late-life depressive symptoms in Europe: an evaluation of the survey version of the EURO-D scale in 10 nations. The SHARE project. Int J Methods Psychiatr Res (2008) 1.27
Methods of synthesizing qualitative research studies for health technology assessment. Int J Technol Assess Health Care (2011) 1.26
IPA survey of brief cognitive screening instruments. Int Psychogeriatr (2006) 1.26
Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur J Epidemiol (2009) 1.25
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry (2014) 1.21
Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep (2012) 1.18
Suicidal behavior is associated with reduced corpus callosum area. Biol Psychiatry (2011) 1.17
Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep (2011) 1.14
Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry (2008) 1.10
Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis (2011) 1.10
Life-time estrogen exposure and cognitive functioning in later life. Psychoneuroendocrinology (2008) 1.07
Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol (2011) 1.05
Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol (2008) 1.04
Social activity and improvement in depressive symptoms in older people: a prospective community cohort study. Am J Geriatr Psychiatry (2009) 1.03
Memory complaints in healthy young and elderly adults: reliability of memory reporting. Aging Ment Health (2008) 1.02
The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study. Stroke (2007) 1.02
Patient and public attitudes to and awareness of clinical practice guidelines: a systematic review with thematic and narrative syntheses. BMC Health Serv Res (2014) 1.01
Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med (2013) 1.01
Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord (2007) 1.00
5-HTTLPR genotype, stressful life events and late-life depression: no evidence of interaction in a French population. Neurobiol Aging (2008) 1.00
Alcohol consumption and carotid artery structure in older French adults: the Three-City Study. Stroke (2004) 0.99
Use of the PRIME-MD Patient Health Questionnaire for estimating the prevalence of psychiatric disorders in French primary care: comparison with family practitioner estimates and relationship to psychotropic medication use. Gen Hosp Psychiatry (2007) 0.97
Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord (2007) 0.96
Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. J Alzheimers Dis (2010) 0.96
Lipid lowering agents, cognitive decline, and dementia: the three-city study. J Alzheimers Dis (2012) 0.95
Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study). Biol Psychiatry (2010) 0.95
Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence. J Alzheimers Dis (2010) 0.95
Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women. Br J Nutr (2009) 0.94
Determinants of excessive daytime sleepiness in a French community-dwelling elderly population. J Sleep Res (2007) 0.94
Excessive daytime sleepiness and vascular events: the Three City Study. Ann Neurol (2012) 0.94
The mental health of doctor-shoppers: experience from a patient-led fee-for-service primary care setting. J Affect Disord (2011) 0.93
Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. J Alzheimers Dis (2010) 0.93
Access with evidence development in the UK: past experience, current initiatives and future potential. Pharmacoeconomics (2010) 0.92
Persistence of abnormal cortisol levels in elderly persons after recovery from major depression. J Psychiatr Res (2008) 0.91
Calf circumference is inversely associated with carotid plaques. Stroke (2008) 0.91
Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psychooncology (2009) 0.91
Measuring resilience in adult women using the 10-items Connor-Davidson Resilience Scale (CD-RISC). Role of trauma exposure and anxiety disorders. PLoS One (2012) 0.90
Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care (2011) 0.90
Revised criteria for Alzheimer's disease: what are the lessons for clinicians? Lancet Neurol (2011) 0.89
Depression history, depressive symptoms, and incident dementia: the 3C Study. J Alzheimers Dis (2011) 0.89
Depressive symptoms, major depressive episode and cognition in the elderly: the three-city study. Neuroepidemiology (2007) 0.89
Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study. PLoS One (2013) 0.89
Insomnia, daytime sleepiness and cardio-cerebrovascular diseases in the elderly: a 6-year prospective study. PLoS One (2013) 0.89
Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City Study. Atherosclerosis (2009) 0.89
Metabolic syndrome, its components, and mortality in the elderly. J Clin Endocrinol Metab (2010) 0.88
Patient-reported outcome measures for chronic obstructive pulmonary disease : the exclusion of people with low literacy skills and learning disabilities. Patient (2013) 0.87
Incidence and persistence of sleep complaints in a community older population. Int J Geriatr Psychiatry (2010) 0.87
Is deafness a disease of poverty? The association between socio-economic deprivation and congenital hearing impairment. Int J Audiol (2004) 0.87
Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry (2003) 0.86
Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Int Psychogeriatr (2008) 0.86
Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychosom Res (2007) 0.86
Subjective memory impairment, objective cognitive functioning and social activity in French older people: findings from the Three Cities study. Geriatr Gerontol Int (2012) 0.86
Olive oil and cognition: results from the three-city study. Dement Geriatr Cogn Disord (2009) 0.86
A prospective study of the bi-directional association between vision loss and depression in the elderly. J Affect Disord (2013) 0.85
Sex differences in the associations between lipid levels and incident dementia. J Alzheimers Dis (2013) 0.85
Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study. PLoS One (2012) 0.84
Is frailty a prodromal stage of vascular dementia? Results from the Three-City Study. J Am Geriatr Soc (2012) 0.84
Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia. PLoS One (2013) 0.84
Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study. Stroke (2009) 0.83
The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease. BMJ Open (2012) 0.83
Lifetime hormonal factors may predict late-life depression in women. Int Psychogeriatr (2008) 0.83
The Tasmanian Healthy Brain Project (THBP): a prospective longitudinal examination of the effect of university-level education in older adults in preventing age-related cognitive decline and reducing the risk of dementia. Int Psychogeriatr (2013) 0.83
Disability and incident coronary heart disease in older community-dwelling adults: the Three-City Study. J Am Geriatr Soc (2010) 0.82
Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective study. J Affect Disord (2012) 0.82
The STAI-Y trait scale: psychometric properties and normative data from a large population-based study of elderly people. Int Psychogeriatr (2012) 0.82
Tea consumption is inversely associated with carotid plaques in women. Arterioscler Thromb Vasc Biol (2007) 0.82
Depression in elderly persons subject to childhood maltreatment is not modulated by corpus callosum and hippocampal loss. J Affect Disord (2012) 0.82
Metabolic syndrome and localization of white matter hyperintensities in the elderly population. Alzheimers Dement (2012) 0.82
Metabolic syndrome and disability: findings from the prospective three-city study. J Gerontol A Biol Sci Med Sci (2013) 0.82
Late life depression and incident activity limitations: influence of gender and symptom severity. J Affect Disord (2011) 0.81
Late-life health consequences of exposure to trauma in a general elderly population: the mediating role of reexperiencing posttraumatic symptoms. J Clin Psychiatry (2011) 0.81
Primary and secondary care consultations in elderly demented individuals in France. Results from the Three-City Study. Dement Geriatr Cogn Disord (2008) 0.81